Corona Remedies gets EU-GMP for Hormone & renewed for OSD facility

CORONA Remedies Limited has received EU-GMP Compliance Certification for its Hormone manufacturing facility and renewed EU-GMP approval for its Oral Solid Dosage (OSD) manufacturing facility at Bhayla, Ahmedabad. These accreditations follow an EUDRA GMP inspection conducted in April 2026. The company states that these milestones strengthen its global manufacturing and quality credentials, reaffirming its commitment to world-class quality systems and international standards. Mr. Viral Sitwala, Executive Director, highlighted that this reflects their commitment to quality and aims to serve both Indian and global regulated/semi-regulated markets, particularly expanding their Hormone portfolio internationally.